Stay updated on Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page has removed extensive details about a randomized phase II study of pembrolizumab in esophageal adenocarcinoma, including the study's aims, inclusion and exclusion criteria, and the principal investigator's name. It has added a new version number and the name of a collaborator.
    Difference
    37%
    Check dated 2025-04-16T14:48:30.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 19, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T10:10:01.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:40:54.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page has updated its date references, removing older dates from 2024 and adding new dates in March 2025. This indicates a shift in the timeline of the content presented.
    Difference
    0.8%
    Check dated 2025-03-25T14:17:25.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T21:15:52.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T10:28:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.